Healixa (EMOR) Stock Price, News & Analysis
Company Description
Healixa (OTC Link: EMOR) is a publicly traded health information services company in the Healthcare sector. The company has a market capitalization of $7.7M.
EMOR stock has gained 404.2% over the past year. Shares last traded at $0.0600.
This page provides a comprehensive overview of EMOR stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Healixa (EMOR) stock last traded at $0.0600, down 10.20% from the previous close. Over the past 12 months, the stock has gained 404.2%. At a market capitalization of $7.7M, EMOR is classified as a micro-cap stock with approximately 766.7M shares outstanding.
Latest News
Healixa has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 6 with negative movement. Key topics include management. View all EMOR news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Healixa (EMOR) currently stands at 6.8 thousand shares, up 13518.0% from the previous reporting period, representing 0.0% of the float. Over the past 12 months, short interest has increased by 664.2%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Healixa (EMOR) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 3.1 days.
EMOR Company Profile & Sector Positioning
Healixa (EMOR) operates in the Health Information Services industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing EMOR often look at related companies in the same sector, including DiagnaMed Holdings Corp (DGNMF), Comprehensive Healthcare Systems (CMHSF), AI / ML Innovations (AIMLF), CompuMed (CMPD), and Careview Comm (CRVW). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate EMOR's relative position within its industry.